Uniunea Europeană - română - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - ozanimod clorhidrat de - multiple sclerosis, relapsing-remitting; colitis, ulcerative - imunosupresoare - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.

Uniunea Europeană - română - EMA (European Medicines Agency)

accord healthcare s.l.u. - fampridine - scleroză multiplă - alte medicamente pentru sistemul nervos - fampridine accord is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (edss 4-7).

Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

merck europe b.v. - cladribinum - comprimate - 10 mg

Uniunea Europeană - română - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - spesolimab - psoriazis - imunosupresoare - spevigo is indicated for the treatment of flares in adult patients with generalised pustular psoriasis (gpp) as monotherapy.